0 CytoDyn says Phase Insurance Institute of India preliminary shows security, mortality decrease, and quicker medical clinic release for Coronavirus patients treated with leronlimab March 8, 2021 Editorial TeamThe group mentioned options of the preliminary info remembered a 24% lower for all-cause mortality
